Liminatus Pharma, Inc. (LIMN)

1.84 -0.21 (-10.24%) USD  |  NASDAQ  |  Feb 06, 16:00
1.76 -0.08 (-4.35%) After-Hours: 06:02
More

Liminatus Pharma Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade